<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-12T02:10:03Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.nprd.000cv" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.nprd.000cv</identifier>
    <datestamp>2026-09-07T10:52:21Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-09-07</dc:date>
  <dc:title>Exploring the Mechanism of Gansui-Gancao Pair in Treating Malignant Ascites Based on Network Pharmacology and Animal Experiments - Raw Data</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.nprd.000cv</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>This study aims to explore the mechanism of Kansui Radix-Glycyrrhizae Radix et Rhizoma (KR-GRR) herb pair on malignant ascites (MA) by using network pharmacology and animal experiment. Firstly, the active components of KR-GRR herb pair and&amp;nbsp;the corresponding targets were screened from the TCMSP database.&amp;nbsp;The common targets and signaling pathways of KR-GRR herb pair in treating MA were predicted by network pharmacology, and a protein-protein interaction network was constructed to form a visualized map of Chinese Tradition medicine-components-diseases-targets. GO and KEGG analyses were used to predict the underlying&amp;nbsp;mechanism of KR-GRR herb pair in treating&amp;nbsp;MA. Secondly, molecular docking was employed&amp;nbsp;to obtain the binding ability of the active components of KR-GRR herb pair to the core targets. Finally, the MA mice model was developed using&amp;nbsp;H22 liver cancer cells for the mechanism validation. As a result, network&amp;nbsp;pharmacology results&amp;nbsp;indicated&amp;nbsp;that&amp;nbsp;13 core bioactive components and 51 potential targets of KR-GRR&amp;nbsp;against&amp;nbsp;MA, with key targets including serine/threonine-protein kinase 1&amp;nbsp;(AKT1), tumor necrosis factor&amp;nbsp;(TNF), interleukin- 6&amp;nbsp;(IL-6), tumor protein 53&amp;nbsp;(TP53), IL-1&amp;beta;, and Matrix metallopeptidase 9&amp;nbsp;(MMP9). A&amp;nbsp;total of 141 signaling pathways&amp;nbsp;were&amp;nbsp;screened out by KEGG analysis, and molecular docking results suggested that the PI3K/AKT1/MMP9 signaling pathway played a pivotal role in the therapeutic effects of KR-GRR against MA. The animal experiment demonstrated that KR-GRR herb pair significantly improved the general condition, survival rate, and peritoneal histopathological damage in MA mice. Additionally, 2.5 g/kg of KR-GRR&amp;nbsp;reduced abdominal circumference and ascites volume, and suppressed the expression of AKT1 and MMP9 in ascitic fluid. Furthermore, KR-GRR downregulated the mRNA levels of&amp;nbsp;AKT1, TNF, IL-6, TP53, IL-1&amp;beta;, and&amp;nbsp;MMP9&amp;nbsp;in peritoneal tissues, as well as the protein expression of p-PI3K, PI3K, p-AKT1, AKT1, and MMP9, especially&amp;nbsp;the ratios of p-PI3K/PI3K and p-AKT1/AKT1. Taken together, KR-GRR herb pair&amp;nbsp;may exert therapeutic effects against MA by inhibiting the activation of the PI3K/AKT1/MMP9 signaling pathway.</dc:description>
  <dc:subject>Network Pharmacology; Animal Experiments; Gansui-Gancao Pair; Malignant Ascites</dc:subject>
  <dc:creator>he tian tian</dc:creator>
  <dc:rights>RESTRICTED</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>